VKTX
NASDAQ
US
Viking Therapeutics, Inc. - Common Stock
$34.80
▲ +$1.84
(+5.58%)
Vol 3.6M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.0B
ROE
-29.3%
D/E
0.00
Beta
0.71
52W
$19–$44
Wall Street Consensus
25 analysts · Apr 20269
Strong Buy
13
Buy
3
Hold
0
Sell
0
Strong Sell
88.0%
Buy Rating
Price Chart
Similar Stocks
IMVT
Immunovant Inc
$5.1B
APGE
Apogee Therapeutics Inc
$5.2B
DNTH
Dianthus Therapeutics Inc
$1.8B
FOLD
Amicus Therapeutics Inc
$4.4B
ACAD
ACADIA Pharmaceuticals Inc
P/E 17.3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B
DNLI
Denali Therapeutics Inc
$2.6B
DYN
Dyne Therapeutics Inc
$3.2B
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.91 | $-1.38 | $-0.47 |
| Sep 2025 | $-0.69 | $-0.81 | $-0.12 |
| Jun 2025 | $-0.46 | $-0.58 | $-0.12 |
| Mar 2025 | $-0.33 | $-0.41 | $-0.08 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -20.0% | -20.0% | -20.0% | -29.3% | -29.3% | -29.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 25.86 | 25.86 | 25.86 | 28.34 | 28.34 | 28.34 |
Key Ratios
ROA (TTM)
-28.4%
P/B
5.1
EPS (TTM)
$-2.12
52W High
$43.55
52W Low
$18.92
$18.92
52-Week Range
$43.55
How does VKTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
VKTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
5.1
▲
107%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
VKTX profitability vs Biotechnology peers
ROE
-29.4%
▲
56%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-28.4%
▲
39%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
VKTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
28.3
▲
538%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.7
▼
27%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
VKTX fundamentals radar
VKTX
Peer median
Industry
VKTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio